The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: kaletra     Quarter: 2016Q3

Total Drug/Injury Combinations: 183     Number of Pages: 10

DRUGNAME PT EventCount
KALETRA Blood glucose increased 1 view events
KALETRA Blood lactate dehydrogenase increased 1 view events
KALETRA Blood lactic acid increased 1 view events
KALETRA Blood potassium abnormal 1 view events
KALETRA Bradycardia 1 view events
KALETRA Brain malformation 1 view events
KALETRA Bronchopulmonary dysplasia 1 view events
KALETRA Burning sensation 1 view events
KALETRA Cardiac disorder 1 view events
KALETRA Catheter site haemorrhage 1 view events
KALETRA Cholestasis of pregnancy 1 view events
KALETRA Choroidal coloboma 1 view events
KALETRA Cleft lip and palate 1 view events
KALETRA Congenital anomaly 1 view events
KALETRA Congenital anomaly of adrenal gland 1 view events
KALETRA Congenital central nervous system anomaly 1 view events
KALETRA Congenital genital malformation 1 view events
KALETRA Congenital hand malformation 1 view events
KALETRA Congenital hepatomegaly 1 view events
KALETRA Coronary artery occlusion 1 view events

Total Drug/Injury Combinations: 183     Number of Pages: 10

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)